Where surgery may fit
Treatment is chosen from the actual stage, tumor biology, lung function, and your goals—not from a stage number alone.
Thoracic surgeons are most commonly involved in stage I and stage II non-small cell lung cancer and in carefully selected stage III disease. For most stage IV lung cancers, removal of the lung tumor is not routine.
Discuss your treatment pathwayBefore treatment is chosen
A treatment plan starts with the correct diagnosis and stage. The team may need diagnostic CT, PET/CT, brain MRI when indicated, pulmonary-function testing, pathology, biomarker testing, and tissue sampling of mediastinal lymph nodes by EBUS/EUS or, selectively, mediastinoscopy.
This overview refers primarily to non-small cell lung cancer. Small cell lung cancer follows a different pathway and is rarely treated with surgery.
Broad outline
How the surgeon's role changes by stage
| Stage | Typical role of surgery |
|---|---|
| Stage I | For a patient who can safely undergo an operation, surgery is often the main curative treatment. The operation may be a lobectomy or, in selected small tumors, an anatomic segmentectomy, together with appropriate lymph-node assessment. Stereotactic body radiation is an important alternative when surgery is not appropriate. |
| Stage II | Surgery is commonly part of treatment when the cancer is resectable and the patient is fit. Chemotherapy, often combined with immunotherapy, may be recommended before surgery. After surgery, chemotherapy, immunotherapy, or biomarker-directed targeted therapy may be recommended according to the pathologic stage, molecular findings, and current evidence. |
| Stage III | Stage III covers very different situations. Some carefully selected, technically resectable cancers may include surgery within a planned combination of systemic therapy and/or radiation. Many others are treated without surgery. A multidisciplinary review is essential before any single treatment starts. |
| Stage IV | For most patients, systemic therapy is the main treatment and removal of the lung tumor is not routine. Rare patients with a limited number of metastases may be considered for focused surgery or radiation after multidisciplinary review. Surgery may also be used to obtain tissue or relieve a selected symptom. |
Why involve a thoracic surgeon early?
A surgeon can help determine whether a tumor is technically removable, whether the patient can tolerate an operation, which lymph nodes need sampling, and whether a minimally invasive resection is appropriate. Early review also reduces the risk of beginning one treatment before the team has considered the complete sequence.
Surgery is only one part of curative-intent care. Even after a complete resection, final pathology and molecular results may support additional treatment. Conversely, a surgical consultation may confirm that radiation or systemic therapy is the better first step.
A coordinated decision—not a website prescription
Lung-cancer treatment changes quickly. We work closely with medical oncologists and radiation oncologists to interpret current evidence for the individual patient. When useful, we also coordinate with pulmonology, radiology, pathology, and local hospitals across the Merrimack Valley and Southern New Hampshire.
Your next step
Let our office help coordinate the pathway
We can review completed testing, identify missing staging information, discuss where surgery may fit, and help connect the medical-oncology and radiation-oncology teams available in the Merrimack Valley and Southern New Hampshire.
Sources and further reading
Sources reviewed September 12, 2026. Recommendations evolve and must be confirmed for each patient.